InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Sweeny Nicole, Directeur Commercial. Director active across 2 companies, notably Praxis Precision Medicines, Inc.. In total, 11 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €32k. Activity tracked since 7 January 2022. The latest transaction was disclosed on 17 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sweeny Nicole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
1,862 股@ US$20.21630.0025% mcap100.0% 占其流量Common StockSEC:0001827505-26-000003:1
6,250 股Common StockSEC:0001827505-26-000003:0
6,250 股Common StockSEC:0001827505-26-000002:0
6,250 股Common StockSEC:0001827505-25-000004:0
5,000 股Common StockSEC:0001415889-25-023075:0
6,250 股Common StockSEC:0001415889-25-022975:0
1,456 股@ US$3.9411.6% 占其流量Common StockSEC:0001689548-23-000051:0
2,079 股@ US$2.5210.8% 占其流量Common StockSEC:0001689548-23-000008:0
2,587 股@ US$8.79847.5% 占其流量Common StockSEC:0001689548-22-000040:0
1,233 股@ US$12.8530.1% 占其流量Common StockSEC:0001689548-22-000008:0
24,000 股0Common StockSEC:0001104659-22-003164:0
11 条申报中的 11 条
About Sweeny Nicole
Sweeny Nicole is Directeur Commercial, and the declarant profile covers 11 filings in total. In the recent filings tracked, they span from 2022-01-11 to 2026-04-20, with EUR 0 of buys and EUR 31947 of sells, the most visible transaction being a sale at KalVista Pharmaceuticals, Inc. on 2026-04-20.
